Best The Jackson Laboratory Podcasts (2024)

1
Building a Professional Community for Laboratory Stewardship 27:46

1h ago27:46

27:46

Since its founding in 2013 at Seattle Children’s Hospital, PLUGS (Patient-Centered Laboratory Utilization Guidance Services) has brought together laboratory professionals, genetic counselors, clinicians, patients, and insurance companies across the country to improve the application of laboratory tests in clinical practice. In this interview, PLUGS…

1
Inside BlueRock Therapeutics' Parkinson's Disease Trial with Dr. Ahmed Enayetallah 29:39

1d ago29:39

29:39

BlueRock Therapeutics' SVP Head of Development, Dr. Ahmed Enayetallah, joins Cell & Gene: The Podcast Host, Erin Harris, to discuss the company's phase I clinical trial for Parkinson’s disease, which continues to show positive trends at 18 months. They cover the important role induced pluripotent stem cells' (iPSCs) play in the trial, and they also…

1
Reducing the Disease Burden of AML with Vor Bio's Dr. Robert Ang 23:08

15d ago23:08

23:08

In 2021 on Episode 13, Vor Bio’s President and CEO, Dr. Robert Ang shared data about the company’s lead engineered hematopoietic cell (eHSC) product candidate. Dr. Ang is back to talk to Cell & Gene: The Podcast Host, Erin Harris, about how Vor has treated 8 patients demonstrating clinical proof of concept and is also in the clinic with a CAR-T tha…

1
Reducing Toxicities in Allogeneic Cell Therapies with Orca Bio's Dr. Scott McClellan 19:37

29d ago19:37

19:37

Orca Bio's CMO, Dr. Scott McClellan, joins Erin Harris on this episode of Cell & Gene: The Podcast to discuss how and why toxicities continue to stymie allogeneic cell therapies. They cover Orca Bio's plan to potentially lowering the risk of GvHD as well as Orca-T, the investigational high-precision allogeneic cell therapy being evaluated in clinic…

1
What It Means for a Laboratory to Be Part of the Patient Care Team 42:14

1M ago42:14

42:14

Dr. Eddie Stenehjem, Vice Chair of Medicine at the University of Colorado, knows a lot about clinical laboratories. As an infectious disease physician and former cochair of Intermountain Healthcare’s laboratory stewardship committee, he has deep respect for the knowledge and dedication that laboratory professionals bring to patient care. In this in…

1
Inside Cellular Rejuvenation Therapies for Age-Related Diseases with Life Biosciences' Sharon Rosenzweig-Lipson, Ph.D. 17:17

1M ago17:17

17:17

On this episode of Cell & Gene: The Podcast, Host Erin Harris talks to Life Biosciences' CSO, Sharon Rosenzweig-Lipson, Ph.D., about the Boston-based biotech's cellular rejuvenation therapies for the treatment of age-related diseases. They cover Life Biosciences' lead program, a gene therapy called OSK that is being advanced in two optic neuropathi…

1
The Future of Rare Diseases with The Jackson Laboratory’s Rare Disease Translational Center's Cat Lutz 27:31

2M ago27:31

27:31

Rare Disease Day is February 29, 2024, and in honor of this important day, Cell & Gene: The Podcast Host Erin Harris sits down with Jackson Laboratory’s (JAX) Rare Disease Translational Center (RDTC)'s VP, Cat Lutz. They discuss RDTC's mission, the specific qualifications that make up a rare disease, how the study of rare diseases can potentially a…

1
How Will Automation Change Clinical Laboratories? 19:54

2M ago19:54

19:54

There’s plenty of excitement around laboratory automation. But which tasks are good candidates for automation, and which are poor candidates? What risks need to be managed? And what are the implications of automation for lab professionals? In this interview, Dr. Joseph Rudolf, medical director of ARUP’s Automated Core Laboratory, shares his insight…

1
Inside Yescarta's Reduced Median Turnaround Time with Kite, a Gilead company's Christopher McDonald 20:48

2M ago20:48

20:48

On this episode of Cell & Gene: The Podcast, Christopher McDonald, Global Head of Technical Operations at Kite, a Gilead company, talks to Host Erin Harris about Kite's recent FDA approval of manufacturing process change resulting in reduced median turnaround time for Yescarta. They talk through the most significant steps Kite took to reach this ap…

1
Pricing, Value, And Access of CGTs With The Dedham Group's Jennifer Klarer, M.Sc.Eng. 37:17

3M ago37:17

37:17

The Dedham Group's Jennifer Klarer, M.Sc.Eng., Partner and Head of Cell & Gene Therapy, joins Erin Harris on this episode of Cell & Gene: The Podcast for a deep dive into pricing and value for CGTs. Klarer shares a detailed breakdown of the most misunderstood aspects of cell and gene therapy pricing, value, and affordability. She details how manufa…

1
Solving Coagulation Mysteries One Patient at a Time 27:59

3M ago27:59

27:59

Diagnosis involves much more than a number on a lab report. This is particularly true when the patient has disordered bleeding or clotting. In this interview, Dr. Karen Moser from the University of Utah Department of Pathology describes some of the ways she works with her laboratory and clinician colleagues to ensure that patients get the answers a…

1
Breaking Down Solid Tumors with Triumvira Immunologics' Dr. Paul Lammers 21:33

3M ago21:33

21:33

Paul Lammers, M.D., M.Sc., CEO of Triumvira Immunologics joins Cell & Gene: The Podcast to talk to Host Erin Harris about TAC, the company's proprietary T cell Antigen Coupler, which has both autologous and allogeneic approaches. They also discuss targeting relapsed or refractory HER2-positive solid tumors and CLDN18.2-positive solid tumors. And th…

1
4 Keys to Allo in 2024 with Poseida Therapeutics' Kristin Yarema, Ph.D. 31:59

4M ago31:59

31:59

Kristin Yarema, Ph.D., CEO, Poseida Therapeutics sits down with Cell & Gene: The Podcast Host Erin Harris to discuss four of the biggest challenges the CGT sector faces when it comes to the development of off-the-shelf therapies. Kristin shares how 2024 might see some real progress in allogeneic therapies.…

1
Cell Therapy For Corneal Endothelial Dystrophies With Aurion Biotech's Greg Kunst 13:41

4M ago13:41

13:41

For this third and final episode recorded at ARM's 2023 Meeting on the Mesa, Cell & Gene: The Podcast Host, Erin Harris, sat down with Greg Kunst, president, CEO, and Board member at Aurion Biotech. Listen in as they discuss the cell therapy used to treat corneal endothelial disease and how Greg navigated the event as a first-timer attending Meetin…

1
The Human Side of Quality Management 29:26

4M ago29:26

29:26

What does it mean to have a quality culture? Technical competence and strict adherence to protocols are certainly part of the story. But so are factors such as workforce engagement and customer service. In this interview, Nancy Ross, assistant director of clinical pathology and quality at Montefiore Medical System and the founder of Improov, a labo…

1
Overcoming the Limitations of CAR T-Cell Therapy with Vittoria Bio's Nick Siciliano, Ph.D. 17:23

5M ago17:23

17:23

Vittoria Biotherapeutics’ CEO, Nick Siciliano, joins Erin Harris on this episode of Cell & Gene: The Podcast to discuss the company's mission to expand the applications for CAR-based therapeutics by employing novel cell engineering and gene editing technologies.By Erin Harris

1
Why Quality Management Is Critical to the Long-Term Success of Healthcare AI 36:21

5M ago36:21

36:21

A public debate is raging around the regulation of artificial intelligence (AI). One side argues that AI is potentially dangerous and needs to be carefully controlled, whereas the other side argues that any regulation would slow innovation. In this interview, Dr. Ryan Metcalf, section chief of Transfusion Medicine and medical director of Transfusio…

1
Gene Therapy Deals, Collaborations, & Partnerships with Astellas' Richard Wilson 25:02

5M ago25:02

25:02

Richard Wilson, Senior Vice President, Primary Focus Lead, Genetic Regulation at Astellas sat down with Cell & Gene: The Podcast's Erin Harris at ARM's 2023 Meeting on the Mesa to discuss the gene therapy deal making landscape as well as Astellas' recent deals and collaborations. They also discussed Astellas' strategic approach since having acquire…

1
The Promise of AAV Gene Therapy with REGENXBIO's Ken Mills 28:34

6M ago28:34

28:34

Ken Mills, CEO, President, and Director at REGENXBIO joins Erin Harris for this episode of Cell & Gene: The Podcast to discuss the company's progress with its Phase I/II Affinity Duchenne trial of RGX-202 for the treatment of Duchenne Muscular Dystrophy. They discuss the future of AAV gene therapy as well as achieving scalability with consistent yi…

1
How FDA Restrictions on Laboratory-Developed Tests Will Harm Patients and Increase Costs 41:45

6M ago41:45

41:45

The FDA recently announced a plan to regulate laboratory-developed tests (LDTs) as medical devices. In this interview, Dr. Meghan Delaney from Children’s National Hospital and Dr. Eric Konnick from the University of Washington explain why many tests that are critical to patient care, particularly in the areas of pediatrics, transplantation, and rar…

1
Inside 2023 Meeting on the Mesa with ARM's COO, Rita Johnson-Greene 16:33

6M ago16:33

16:33

Alliance for Regenerative Medicine's COO, Rita Johnson-Greene, joined Cell & Gene: The Podcast host, Erin Harris, in person at the 2023 Meeting on the Mesa to discuss this year's event. Johnson-Greene also shared what's ahead for 2024 as the event heads to a new location. They discussed major topics and trends at the event as well as ARM's GROW int…

1
What the TRUU-Lab Initiative Has Taught Us About Laboratory Test Names 24:46

7M ago24:46

24:46

Dr. Ila Singh, chief of laboratory medicine at Texas Children’s Hospital, founded the Test Renaming for Understanding and Utilization in the Laboratory (TRUU-Lab) initiative several years ago to tackle challenges related to the nonstandardized and uninformative naming of laboratory tests. In this interview, Dr. Singh describes the surveys her CDC-f…

1
The Future of Cell and Organ Transplantation in Treating T1D with Dr. Camillo Ricordi 18:15

7M ago18:15

18:15

A pioneer and an icon in diabetes research, Camillo Ricordi, M.D., is the Professor of Surgery, Director of Cell Transplant Center and Director Emeritus of the Diabetes Research Institute at the University of Miami Miller School of Medicine, Florida (UM-DRI). He joins Cell & Gene: The Podcast's Erin Harris to discuss the biggest and most troubling …

1
In Vivo CAR T-Cell Therapeutics With Umoja Biopharma's Dr. Andrew Scharenberg 30:37

7M ago30:37

30:37

Umoja Biopharma's CEO, Andy Scharenberg, M.D., joins Cell & Gene: The Podcast's Erin Harris to discuss the evolution of allogeneic, in vivo CAR-T cell therapeutics. They discuss The Climb, or The Colorado Laboratory and Innovation Manufacturing Building, which is Umoja’s lentiviral vector development and manufacturing facility. They also cover rece…

1
Inside Genome Editing with CBER's Dr. Peter Marks 25:17

8M ago25:17

25:17

The FDA's Center for Biologics Evaluation and Research (CBER)'s Dr. Peter Marks makes his second appearance on Cell & Gene: The Podcast. This time Dr. Marks talks to Host, Erin Harris, about base editing and prime editing and their potential to meet unmet medical need. They discuss what clinical holds say about the FDA’s views on gene editing. They…

1
The Future of CAR-T with Bristol Myers Squibb's Lynelle Hoch 25:53

8M ago25:53

25:53

As SVP Cell Therapy Franchise Lead at Bristol Myers Squibb, Lynelle Hoch leads her team to bring more curative cell-based therapies to patients. She joins Cell & Gene: The Podcast's Host, Erin Harris, to discuss the near-term future of CAR-T. They also take a deep dive into the various innovations and patient access progress being made in both soli…

1
Blunt Advice for Navigating a Career in Academic Medicine 31:24

8M ago31:24

31:24

Individuals pursue careers in academic medicine for many reasons. A love of organizational politics is rarely one of them, but faculty need to understand potential landmines if they are to avoid them. In this interview, Dr. Michael Cohen, a professor emeritus of pathology at Wake Forest University, draws on his experiences serving on faculty and in…

1
The Promise of Genome Editing with Caribou Biosciences' Rachel Haurwitz, Ph.D. 23:21

9M ago23:21

23:21

On this episode of Cell & Gene: The Podcast, Rachel Haurwitz, Ph.D., CEO at Caribou Biosciences joins Host Erin Harris to discuss the evolution of genome editing, its present state, as well as its undeniable potential. They also discuss Caribou's chRDNA genome editing technology and how it differs from CRISPR-Cas9.…

1
Sustainability in Healthcare Organizations 37:36

9M ago37:36

37:36

Sustainability is a hot topic for American corporations, and health systems are no exception. In this interview, Glen Garrick, system sustainability director for Intermountain Healthcare, explains how his and other healthcare organizations are addressing their environmental, social, and governance responsibilities. He also describes how clinical la…

1
Focus Areas For Cell Therapy With Bristol Myers Squibb's Stephan Krause, Ph.D. 19:29

9M ago19:29

19:29

In June 2023, PDA held its Advanced Therapy Medicinal Products Conference in Baltimore, MD. At the conference, Stephan Krause, Ph.D., Executive Director, AS&T, CT Global Quality at Bristol Myers Squibb, sat down with Cell & Gene: The Podcast Host Erin Harris to discuss the event's major themes and topics as well his focus areas for cell therapy in …

1
Keys to Laboratory Success in the Next Pandemic 40:01

9M ago40:01

40:01

Three and a half years after the emergence of COVID-19 is a good time to reflect on the capabilities of U.S. laboratories to respond to future pandemics. In this interview, Dr. Marc Couturier, medical director of Emerging Public Health Crises at ARUP Laboratories, explains how the U.S. laboratory sector has improved in its ability to respond quickl…

1
Optimizing Laboratory Testing for Autoimmune Neurologic Disease 33:07

9M ago33:07

33:07

Laboratory testing can either lead to the correct diagnosis or take a clinician down a blind alley, depending on how carefully the tests are selected and performed. In this interview, a practicing neurologist (Dr. Tammy Smith) and a clinical laboratory immunologist (Dr. Lisa Peterson) explain some of the complexities of laboratory diagnosis of auto…

1
The Intersection Of RNA, AI, And Synthetic Biology With Shape Therapeutics' Dr. Francois Vigneault 29:17

10M ago29:17

29:17

Dr. Francois Vigneault, Co-Founder, President, and CEO at Shape Therapeutics joins Cell & Gene: The Podcast's Erin Harris to discuss how RNA technologies are shaping the future of gene therapy. They also discuss AI's role in gene therapy as well as the how the CGT sector is benefiting from RNA, AI, and synthetic biology.…

1
Bridging the Cultural Divide Between Nursing and Laboratory Medicine 32:51

10M ago32:51

32:51

Nurses and laboratory professionals rely on each other to ensure accurate test results, but their relationships are sometimes challenging. As president of St. Alphonsus Medical Center in Nampa, Idaho, as well as a registered nurse with a doctorate degree in nursing practice, Clint Child often mediates when these two professional cultures collide. I…

1
Inside Prime Editing with Prime Medicine's Dr. Andrew Anzalone 24:34

10M ago24:34

24:34

Dr. Andrew Anzalone, Head of the Prime Editing Platform and Scientific Co-Founder of Prime Medicine joins Cell & Gene: The Podcast to talk with Host Erin Harris about prime editing - what it is and why it is a major technological advancement in gene editing. Anzalone explains why prime editing has a broad applicability for different tissue and cell…

1
Navigating CMC Challenges with Parenteral Drug Association's Glenn Wright 24:55

10M ago24:55

24:55

Glenn Wright, President and CEO of Parenteral Drug Association (PDA), sat down with Cell & Gene: The Podcast's Erin Harris at the 2023 PDA ATMP conference to discuss not only the conference's theme, “Navigating Through CMC Challenges,” but also Wright's take on CGT manufacturing strategy based on his years in industry. Wright shares his insight on …

1
Why Different Platforms Can Give Different Results for the Same Test, and What Can Be Done About It 37:07

11M ago37:07

37:07

Physicians and patients expect laboratory tests to produce the same results, regardless of where they are performed. Unfortunately, that’s not always the case, even for FDA-approved assays. As the current chair of the College of American Pathologists committee for accuracy-based proficiency testing, Dr. Andy Hoofnagle is an authority on this indust…

1
An Interview with Dr. Usman "Oz" Azam 27:37

11M ago27:37

27:37

Dr. Usman "Oz" Azam is CEO of Inspirna now but has spent much of his career in the cell and gene therapy space dedicating years as Novartis’ Global Head of Cell & Gene Therapy, President and CEO of Tmunity Therapeutics, and more. Given Oz’s tenure in cell and gene therapy space, I invited him to Cell & Gene: The Podcast to get his valuable take on …

1
Targeting Oncogenic Drivers for Solid Tumor Cancers with Affini-T Therapeutics' Dr. Jak Knowles 23:45

11M ago23:45

23:45

Affini-T Therapeutics combines a validated TCR discovery platform with synthetic biology switches to attack tumor biology at its root cause. Co-Founder, CEO, and President Dr. Jak Knowles joins Cell & Gene: The Podcast Host Erin Harris to discuss how the company engineers immune cells to target oncogenic driver mutations, such as KRAS, the most pre…

1
TJU's Jefferson Institute for Bioprocessing's Impact on CGT with Parviz Shamlou 42:20

12M ago42:20

42:20

Parviz Shamlou, Vice President and Executive Director at Thomas Jefferson University joins Cell & Gene: The Podcast to talk to Host Erin Harris about Jefferson Institute for Bioprocessing (JIB), the full-service development and training organization specializing in biopharmaceuticals and biologics. Shamlou explains how JIB will move forward cell an…

1
Lessons Learned From Automating a Hospital Laboratory 31:40

1y ago31:40

31:40

The key to successful clinical lab automation doesn’t lie in the instruments or the conveyor belt. It lies in clarifying what the organization most needs to improve (labor efficiency? turnaround time? reliability?) followed by optimizing those factors through modeling and planning. In this interview, Dr. Lauren Pearson, ARUP’s chief medical officer…

1
Computational Biology's Role In Gene Therapy With Kriya Therapeutics' Dr. Shankar Ramaswamy 31:57

1y ago31:57

31:57

Shankar Ramaswamy, M.D., CEO & Co-Founder, Kriya Therapeutics joins Cell & Gene: The Podcast's Erin Harris for a discussion on the evolving role computational biology plays in gene therapy development. They also discuss the company's lessons learned from building its own North Carolina-based in-house manufacturing facility as well as Ramaswamy's in…

1
The Near-Term Future of Exosome Science with Capricor Therapeutics' Dr. Linda Marbán 28:17

1y ago28:17

28:17

Dr. Linda Marbán, Ph.D., CEO of Capricor Therapeutics, a clinical-stage biotech focused on the development of cell and exosome-based therapeutics for the treatment and prevention of serious diseases, joins Cell & Gene: The Podcast's Erin Harris to discuss the current state and the near-term future of exosomes. Marbán discusses Capricor’s exosome pr…

1
What Laboratory Leaders Aren’t Discussing With Hospital Administrators, But Should Be 25:32

1y ago25:32

25:32

For her doctoral dissertation, Dr. Susan Edralin dove into the issue of communicating the value contribution of pathology and laboratory medicine to healthcare administrators. What she found in her conversations surprised her. In this interview, she lists some of the misunderstandings regarding laboratory value and describes how lab directors can r…

1
Inside the World's First-Ever Allogeneic Approval with Atara Biotherapeutics' Pascal Touchon 40:51

1y ago40:51

40:51

In December 2022, Atara Biotherapeutics’ Ebvallo received European Commission approval as the first-ever therapy for adults and children with EBV+ PTLD. The ground-breaking approval represents the first approval of an allogeneic T-cell immunotherapy ever, globally. Atara Bio's CEO, Pascal Touchon, talks to Cell & Gene: The Podcast's Erin Harris abo…

1
Understanding the U.S. Patent System 32:15

1y ago32:15

32:15

You know what a patent is, but do you know what’s patentable in the field of laboratory diagnostics? Or how patent law has changed over the years? In this interview, Dr. Bert Ley, a registered patent agent with decades of experience in the clinical laboratory industry, unpacks some of the mysteries of the U.S. patent system and how it ultimately be…

1
The Potential of RNA Exon Editing with Ascidian Therapeutics' Romesh Subramanian, Ph.D. 20:40

1y ago20:40

20:40

Cell & Gene: The Podcast Host, Erin Harris, welcomes Romesh Subramanian, Ph.D., CEO of Ascidian Therapeutics, a Boston-based biotech focused on rewriting RNA to the pod. During the episode, Subramanian defines RNA exon editing, and they discuss the differences between RNA exon editing and gene editing. With current programs in ophthalmology, neurol…

1
Automating Processes to Scale CGT Manufacturing with PA Consulting's Paolo Siciliano 31:52

1y ago31:52

31:52

When it comes to manufacturing, many cell and gene therapy companies struggle to automate the diverse processes needed to scale manufacturing. London-based PA Consulting's Associate Partner, Paolo Siciliano, talks to Cell & Gene: The Podcast's Erin Harris about how lean, small biotechs with limited resources and limited funds can strive for automat…

1
The Why Behind In-House Manufacturing With Sangamo's Andy Ramelmeier 21:42

1y ago21:42

21:42

On this episode of Cell & Gene: The Podcast, Host Erin Harris talks to Andy Ramelmeir, EVP Head of Technical Operations at Sangamo Therapeutics, a biotech based in Brisbane, California that applies cell and gene therapy to combat Hemophilia A and other genetic diseases. Ramelmeir explains the why behind the company's decision to build its own Phase…

1
2023 Market Outlook with AdBio and ISCT's Miguel Forte 26:34

1y ago26:34

26:34

Miguel Forte is Entrepreneur in Residence at AdBio, a VC firm based in France, and President Elect of ISCT. Forte and Cell & Gene: The Podcast host, Erin Harris, break down market outlook perspective for the cell and gene therapy space. He provides valuable tips to employ when seeking VC partnership, and he covers ISCT's primary focus areas and wha…

Podcasts Worth a Listen

The Jackson Laboratory Podcasts

Podcasts Worth a Listen

Quick Reference Guide